Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database-Reference-Cited by-同舟云学术

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

Published:2020-09-28 Issue:11 Volume:11 Page:3357-3364
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Campos‐Balea Begoña¹^ORCID,Castro Carpeño Javier²,Massutí Bartomeu³,Vicente‐Baz David⁴,Pérez Parente Diego⁵,Ruiz‐Gracia Pedro⁵,Crama Leonardo⁵,Cobo Dols Manuel⁶

Affiliation:

1. Oncology, Hospital Universitario Lucus Augusti (HULA) Lugo Spain

2. Oncology Hospital Universitario La Paz Madrid Spain

3. Oncology Hospital Universitario Alicante (ISABIAL) Alicante Spain

4. Oncology Hospital Universitario Virgen Macarena Seville Spain

5. Lung Cancer. Medical Affairs Department, Roche Farma S.A Madrid Spain

6. Medical Oncology, Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria. IBIMA Málaga Spain

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13681

Reference48 articles.

1. World Health Organization (WHO). Cancer. [Cited April 30 2020.] Available from URL:https://webcache.googleusercontent.com/search?q=cache:R9_054PCc_EJ:https://www.who.int/news-room/fact-sheets/detail/cancer+&cd=1&hl=es&ct=clnk&gl=es.

2. Small Cell Lung Cancer

3. The 2015 World Health Organization Classification of Lung Tumors

4. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

5. Lung cancer in never smokers – A review

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noggin contributes to brain metastatic colonization of lung cancer cells;Cancer Cell International;2023-11-28

2. PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement;Journal of Clinical Medicine;2023-08-01

3. Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?;Journal of Cancer Research and Clinical Oncology;2023-07-22

4. Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?;Diagnostics;2023-05-29

5. Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial;Lung Cancer;2023-04